Risk of second primary malignancies (SPM) following radioactive I-131 (RAI) therapy in patients with differentiated thyroid cancer (DTC)

被引：0
作者：
Ansari, Aiysha [1 ]
Kulkarni, Kanchan [1 ]
Van Nostrand, Douglas [1 ]
Khorjekarand, Gauri [1 ]
Garcia, Carlos [1 ]
机构：
[1] WHC, Nucl Med, Washington, DC USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2010年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1084
引用
收藏
页数：1
相关论文
共 50 条
[41]   I-131 biokinetics of remnant normal thyroid tissue and residual thyroid cancer in patients with differentiated thyroid cancer [J].
Kim, Choon-Young ;
Son, Seung Hyun ;
Jung, Ji-hoon ;
Kim, Do-Hoon ;
Jeong, Shin Young ;
Lee, Sang-Woo ;
Lee, Jaetae ;
Ahn, Byeong-Cheol .
JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
[42]   TESTICULAR DAMAGE AFTER RADIOACTIVE IODINE (I-131) THERAPY FOR THYROID-CANCER [J].
HANDELSMAN, DJ ;
TURTLE, JR .
CLINICAL ENDOCRINOLOGY, 1983, 18 (05) :465-472
[43]   I-131 treatments for differentiated thyroid carcinoma (DTC) in children and adolescents: A 37 year experience on 75 patients [J].
Dottorini, ME ;
Vignati, A ;
Mazzucchelli, L ;
Lomuscio, G ;
Colombo, L .
JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) :1062-1062
[44]   Thyroid hormone replacement one day before I-131 therapy in patients with well-differentiated thyroid cancer [J].
Kayano, Daiki ;
Inaki, Anri ;
Nakamura, Ayane ;
Wakabayashi, Hiroshi ;
Fukuoka, Makoto ;
Kinuya, Seigo .
JOURNAL OF NUCLEAR MEDICINE, 2011, 52
[45]   DIFFERENTIATED THYROID CANCER IN PEDIATRIC POPULATION ( ≤18 YEARS): POSTOPERATIVE TREATMENT WITH RADIOACTIVE IODINE (I-131) [J].
Prpic, Marin ;
Franceschi, Maja ;
Jukic, Tomislav ;
Kust, Davor ;
Dabelic, Nina ;
Varjacic, Tea ;
Lucijanic, Marko ;
Bolanca, Ante ;
Kusic, Zvonko .
ACTA CLINICA CROATICA, 2019, 58 (01) :119-127
[46]   Unexpected radioactive iodine accumulation on whole-body scan after I-131 ablation therapy for differentiated thyroid cancer [J].
Iwano, Shingo ;
Ito, Shinji ;
Kamiya, Shinichiro ;
Ito, Rintaro ;
Kato, Katsuhiko ;
Naganawa, Shinji .
NAGOYA JOURNAL OF MEDICAL SCIENCE, 2020, 82 (02) :205-215
[47]   KINETICS OF LARGE THERAPY DOSES OF I-131 IN PATIENTS WITH THYROID CANCER [J].
SINGH, B ;
SHARMA, SM ;
PATEL, MC ;
RAGHAVEN.KV ;
BERMAN, M .
JOURNAL OF NUCLEAR MEDICINE, 1974, 15 (08) :674-678
[48]   Red marrow Absorbed Dose in Patients Treated with I-131 for Differentiated Thyroid Cancer [J].
Barquero Sanz, M. ;
Ruano, R. ;
Rodriguez, D. ;
de la Llana, V. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 :S608-S608
[49]   Prognostic indicators in patients with differentiated thyroid cancer receiving repeated I-131 therapies [J].
Storto, G. ;
Liuzzi, R. ;
Klain, M. ;
Albanese, C. ;
Salvatore, B. ;
Pellegrino, T. ;
Cella, L. ;
Soricelli, A. ;
Pace, L. ;
Salvatore, M. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 :S329-S329
[50]   Association Between Radioactive Iodine Treatment for Pediatric and Young Adulthood Differentiated Thyroid Cancer and Risk of Second Primary Malignancies [J].
Pasqual, Elisa ;
Schonfeld, Sara ;
Morton, Lindsay M. ;
Villoing, Daphnee ;
Lee, Choonsik ;
Berrington de Gonzalez, Amy ;
Kitahara, Cari M. .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (13) :1439-+
12345